Reference:

1. Parameswaran, V., Linda Ficociello, Mullon, C., Chatoth, D., Kraus, M., Giles, H., Anger, M., Alterations to Peritoneal Dialysis Prescriptions in the First 120 Days of Dialysis May Reduce the  Risk of Attrition [Abstract]. ASN 2021
   

Indications for Use: The Fresenius Liberty Select Cycler is indicated for acute and chronic peritoneal  dialysis.

Caution: Federal (U.S.) law restricts these devices to sale by or on the order of a physician.

Note: Read the Instructions for Use for safe and proper use of these devices. For a complete  description of hazards, contraindications, side effects, and precautions, see full package  labeling at www.fmcna.com.

Use: The Kinexus Portal is intended to allow clinicians to review patient data  collected during peritoneal dialysis therapy and to enable physicians to create peritoneal  dialysis therapy programs for the Liberty Select Cycler. The Kinexus portal does not provide  medical diagnoses or recommendations regarding medical treatment. The Kinexus Portal and  the content appearing on this site are not substitutes for professional medical advice,  diagnosis, or treatment.

Use: The Kinexus Gateway is intended for transmission of home dialysis therapy data and patient data for patients using certain Fresenius products, including peritoneal dialysis cycler(s).

Kinexus is not an electronic health record (EHR) or billing solution

Distributed by NxStage Medical, Inc., a subsidiary of Fresenius Medical Care.

© 2022 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, Kinexus, Liberty, Liberty Select, VersiPD, stay·safe and NxStage are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners.  P/N 103369-01 Rev I 01/2023